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C-Reactive Protein 
Potential Significance of Quanti tat ion 
in Patients wi th Chronic Diseases* 
Hajime Hayashi, Ph.D.** and Gerald A. LoGrippo, M.D.*' 
Serum C-reactive protein (CRP) levels in 351 patients with certain chronic 
diseases were assayed by a micro-double immunodiffusion technique developed 
and used in this hospital. Elevation of CRP values and severity of disease were 
evident in the following clinical entities: 31 of 54 patients (57%) with liver 
cirrhosis; 122 of 204 (60%) hepatitis patients; 34 of 52 (65%) patients with 
gastro-intestinal surgery; 8 of 21 (38%) uremic patients; and all of 20 patients 
with renal transplantation. There was good correlation between markedly 
elevated serum CRP values and degree of inflammation and/or physiologic 
stress during clinical course and recovery. 
Serum C-reactive protein (CRP) 
offers an important index in evaluating 
patients with a wide variety of diseases, 
especially acute and chronic inflamma-
tory conditions. Although the biologic 
nature of CRP in clinical disease is 
incompletely known, numerous inves-
tigators have emphasized its signifi-
cance as an index to persistent inflam-
mation and physiologic stress when 
'^ 'Presented in part before the annual meet-
ing of American Society for Microbiology, 
April 1972 at Philadelphia, Pa. 
*'-Division of Immunology and Virology, 
Department of Pathology. 
Reprint requests should be addressed to the 
the authors c/o Henry Ford Hospital, 
Detroit MI 48202 
Other tests for residual inflammation 
return to normal. 
A quantflative method for assaying 
CRP levels in serum (on a mg per 
cent basis) was developed in our lab-
oratory." Our micro-double immuno-
diffusion technique was applied to 
serum specimens from patients with 
varied pathological conditions. It offers 
another parameter in the battery of 
tests for evaluating the immunologic 
status of patients with chronic dis-
e a s e s . O t h e r tests employed for 
immunologic status of the individual 
are serum immunoglobulins (IgG, 
IgA, IgM and IgE) complement (CHr,o 
and Beta-ir/iA globulin); and antibody 
responses to common micropathogens 
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TABLE I 
SERUM C-REACTIVE PROTEIN LEVELS 
IN VARIOUS CLINICAL ENTITIES 
Clinical 
Entity 
Total 
Tested 
Percent of 
1 - 10 mg'5 
Patients with 
0 > 10 mg% 
Normal* 750* 5.5% 0% 
Liver Cirrhosis 54 41 17 
Virus Hepatitis 204 40 20 
Gastro-intestinal 
Surgery 52 23 42 
Uremia 21 33 5 
Kidney Transplant. 20 25 75 
*95 percentile of normal showed less than 1 mg % 
(10 enteric and several upper respira-
tory viruses, 3 gram-negative enteric 
bacteria, staphylococci and two tox-
oids)."'i= 
The purpose of this presentation is 
to discuss the potential significance of 
the quantitation of CRP in certain 
particular chronic diseases. 
Materials and Methods 
Serum specimens were obtained 
from 351 patients with a variety of 
chronic conditions, and kept sterile 
during collection and storage until 
quantitation of C-reactive protein was 
performed using our technique. For 
controls, we used 750 blood bank 
donors to represent a supposedly 
healthy population. 
Elevation of serum CRP levels 
greater than one mg per cent was 
considered to have clinical significance 
since only 5.5% of the 750 blood bank 
donors fell into this range of serum 
values. 
Results 
The 351 patients studied included 
54 with liver cirrhosis; 204 with viral 
hepatitis; 52 undergoing gastro-intes-
tinal surgery; 21 uremic patients; and 
20 who had received kidney trans-
plantation. The clinical conditions re-
ported here comprised those disease 
entities which warranted serial serum 
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studies and offered an adequate follow-
up of serum specimens for this evalu-
ation. The data, as summarized in 
Table I , are divided into two columns 
(1-10 mg per cent and greater than 10 
mg per cent) to emphasize the degree 
and variation of CRP levels found 
among the respective clinical entities. 
In cirrhosis of the liver, 41% of 
patients had 1 to 10 mg per cent serum 
values of CRP; whereas 17% showed 
10 mg per cent or greater values, 
making a total of 58% who had CRP 
values above the normal controls. 
Among 204 patients with viral hepa-
titis, we found a range of CRP values 
similar to those with cirrhosis. Among 
patients with gastro-intestinal surgery, 
42% showed elevations above 10 mg 
per cent with frequent rises above 100 
mg per cent. Only 5% of the uremic 
patients had elevated CRP values 
above 10 mg per cent whereas 75% 
of those having kidney transplantation 
had CRP values above 10 mg per cent. 
The data indicated that the severity 
of the clinical condition usually corre-
lates well with fluctuations and marked 
elevations of serum CRP levels. This 
is exemplified in Figure 1 which lists 
CRP levels in uremic patients mea-
sured (a) during uremia, (b) after 
nephrectomy and chronic dialysis, and 
(c) after renal transplantation. Six ex-
amples among 20 patients are plotted 
to show two extreme trends. The sera 
of three patients (KT-1, KT-3 and 
KT-4) revealed relatively low or un-
detectable CRP levels in the routine 
assays over a 3-year period of study. 
Although elevations of CRP were seen 
on occasion, such as after surgery, 
the levels returned to normal during 
the usual recovery period. This seemed 
to correlate well with the uncompli-
cated course of recovery. Three other 
patients (KT-2, KT-9 and KT-13) had 
persistent elevated serum CRP levels. 
In two of these, the serum values in-
creased to 70 mg per cent or greater, 
(KT-9 and KT-13) and these high 
CRP levels persisted until death. 
Discussion 
As emphasized in our previous pub-
lication," the micro-double immuno-
diffusion technique has the following 
advantages over the capillary tube 
method for CRP determinations: (1) 
differentiation and identification of the 
specific, precipitable reactant (CRP) 
from non-specific precipitable reactants 
which are inclusive in the values ob-
tained with the tube method; (2) in-
creased sensitivity; and (3) quantitative 
values expressed in mg per cent for a 
specific protein (CRP) in lieu of total 
precipitation expressed in millimeters 
by the capillary tube method. 
The advantages in the improved 
method should reassure the clinician 
of the value of these measurements for 
CRP in chronic diseases. The tube 
method frequently gives false positive 
values and has the disadvantage of 
limited quantitation (a maximum of 
6 plus in total tube precipitation). The 
degrees and variations of serum CRP 
values in mg per cent appear to reflect 
the degree of inflammatory stress upon 
the host in certain disease states, as 
well as revealing unresolved inflamma-
tion when other tests return to normal. 
Moreover, unusually high and persis-
tent elevations of CRP (values above 
70 mg per cent) suggest a critical state 
of inflammation or physiological stress. 
Good correlation was found between 
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Serum C-Reactive Protein Levels 
in Patients 
with Kidney Transplantation (K.T.) 
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Figure 1 
serum CRP values and inflammatory 
stress during the clinical course and 
recovery period of the diseases evalu-
ated. 
Conclusion 
Serum levels of CRP in various clin-
ical pathologic settings were studied. 
Quantitation of these values seems to 
have an additional advantage over the 
tube precipitation method in general 
use. We found particularly interesting 
the markedly elevated serum levels of 
CRP in patients experiencing failure of 
kidney transplants. Multiple para-
meters"-^' are used in an attempt to 
evaluate rejection crisis in these pa-
tients, and the CRP may well be a 
worthwhile test to add to the battery 
of tests presently used to evaluate this 
problem. 
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